Near future
No Result
View All Result
June 3 2023
  • Home
  • Tech
  • Health
  • Environment
  • Energy
  • Inland solutions
  • Spazio
  • AI
  • concepts
  • H+
Understand, anticipate, improve the future.
CES2023 / Coronavirus / Russia-Ukraine
Near future
  • Home
  • Tech
  • Health
  • Environment
  • Energy
  • Inland solutions
  • Spazio
  • AI
  • concepts
  • H+

Understand, anticipate, improve the future.

No Result
View All Result
Medicine

New vaccine for Epstein Barr virus: human experimentation begins

If it works, the new Epstein Barr virus vaccine will protect people from mononucleosis and possibly multiple sclerosis.

May 13, 2022
Gianluca RiccioGianluca Riccio
⚪ 3 minutes
Share70Pin17Tweet44SendShare12ShareShare9
Epstein Barr virus

Epstein Barr virus

READ THIS IN:

Epstein Barr virus (EBV) is a virus of the herpes family that spreads through saliva and which it affects about 9 out of 10 people, although many are unaware of it because they are generally asymptomatic.

Like other herpesviruses (including chickenpox, shingles and cold sores) once Epstein Barr infects a person it stays in their body forever hiding in their cells, but can periodically reactivate causing new symptoms.

An insidious enemy

The Epstein Barr virus is primarily known to cause mononucleosis (also known as the "kissing disease"). It causes extreme fatigue, fever and sore throat, and can last for weeks or even months. 

However, EBV has long been associated with an increased risk of certain cancers and autoimmune diseases, the worst of which is multiple sclerosis.

The article continues after the related links

Moderna: "Cancer and heart disease vaccines ready by 2030"

Approved the first vaccine against plague of bees

In January 2022, a Harvard team released the results of a study conducted on ten million young people. It is revealed that those infected with the Epstein Barr virus have 32 times more likely to develop multiple sclerosis. It was the first comprehensive study that provides compelling evidence for this causation.

"A big step," says the Italian Alberto Ascherio, a professor at the Harvard School of Public Health and lead author of the research. "It suggests that most cases of multiple sclerosis could be prevented by stopping Epstein Barr virus infection. Studying this virus better may lead to the discovery of a cure for multiple sclerosis: if you are not infected, the risk of developing it is practically zero ".

alberto ascherio epstein barr
The professor. Alberto Ascherio, one of the authors of the study that identified the correlation between Epstein Barr virus and multiple sclerosis

A vaccine against the Epstein Barr virus

The US National Institute of Allergy and Infectious Diseases (NIAID) has experimentation started phase 1 of an Epstein Barr virus vaccine. The vaccine targets a molecule found on the surface of the virus, called glycoprotein 350. It is the same molecule that the neutralizing antibodies of the immune system attack when there is an EBV infection.

In this study, the researchers will give 40 healthy young adults between the ages of 18 and 29 three doses of the Epstein Barr vaccine. The goal is to determine the safety of the vaccine and see what kind of immune response it requires. 

The fight has started

Developing herpesvirus vaccines is not easy, given their ability to "hide" from our immune system. In particular, Epstein Barr, which until a few months ago was not considered a priority.

However, the fact that it can cause multiple sclerosis has accelerated everyone's efforts. Moderna, one of the pharmaceutical companies that developed mRNA vaccines against Covid, is also currently testing a possible vaccine. And vaccines aside, they are being tested (with excellent results) also specific immunotherapies.

We may be close to knocking out the cause of one of the most disabling conditions, which can cause a lot of suffering to those with it.

Tags: Multiple sclerosisvaccines


GPT Chat Megaeasy!

Concrete guide for those approaching this artificial intelligence tool, also designed for the school world: many examples of applications, usage indications and ready-to-use instructions for training and interrogating Chat GPT.

To submit articles, disclose the results of a research or scientific discoveries write to the editorial staff

Most read of the week

  • Oculus gives VR visit to the Anne Frank house

    268 Shares
    Share 107 Tweet 67
  • Sucralose, the bitter truth: the sweetener damages DNA

    4 Shares
    Share 1 Tweet 1
  • Here comes a new magnetic field reversal. We are ready?

    4 Shares
    Share 1 Tweet 1
  • Inhale, exhale, remember: the links between breath and memory are getting stronger and stronger

    4 Shares
    Share 1 Tweet 1
  • Look what's on my mind: an AI that transforms thoughts into HQ Videos

    4 Shares
    Share 1 Tweet 1

Enter the Telegram channel of Futuroprossimo, click here. Or follow us on Instagram, Facebook, Twitter, Mastodon e LinkedIn.

The daily tomorrow.


Futuroprossimo.it provides news on the future of technology, science and innovation: if there is something that is about to arrive, here it has already arrived. FuturoProssimo is part of the network ForwardTo, studies and skills for future scenarios.

FacebookTwitterInstagramTelegramLinkedInMastodonPinterestTikTok
  • Environment
  • Architecture
  • Artificial intelligence
  • Gadgets
  • concepts
  • Design
  • Medicine
  • Spazio
  • Robotica
  • Work
  • Inland solutions
  • Energy
  • Edition Francaise
  • Deutsche Ausgabe
  • Japanese version
  • English Edition
  • Portuguese Edition
  • Русское издание
  • Spanish edition

Subscribe to our newsletter

  • The Editor
  • Advertising on FP
  • Privacy Policy

© 2022 Near future - Creative Commons License
This work is distributed under license Creative Commons Attribution 4.0 International.

No Result
View All Result
Understand, anticipate, improve the future.
  • Home
  • Tech
  • Health
  • Environment
  • Energy
  • Inland solutions
  • Spazio
  • AI
  • concepts
  • H+